1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. IN8BIO INC
IN8bio Inc
XNAS: INAB
Download real time
1.38-0.02(-1.43%)
49.45% Fall from 52W High
20,917
XNAS Volume

XNAS 08 Oct, 2026 5:30 PM (EDT)

Portfolio

Alert

My Notes

IN8bio Inc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

IN8bio Inc quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
Nested row level
Base Level
Export
  • NEUTRAL

    Quarterly Revenue IN8bio Inc Jun-2026 Quarterly Revenue is $0 Million which is growth of 0% YoY.

  • POSITIVE

    Quarterly Net Profit IN8bio Inc Jun-2026 Quarterly Net Profit is $-5 Million which is growth of 6.1% YoY.

IN8bio Inc, Earnings Report - Quarterly Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphJun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23
Operating Rev.
Cost Of Rev.
-------------
Gross Profit
-------------
⌄
4.95.3545.25.76.268.78.67.97.27.7
Operating Profit
-4.9-5.3-5-4-5.2-5.7-6.2-6-8.7-8.6-7.9-7.2-7.7
⌄
0.20.20.10.10.10.10.100.10.1---
Profit Before Tax
-4.8-5.1-4.9-3.9-5.1-5.6-6.2-7.1-8.6-8.6-7.6-7.2-7.7
Tax
-------------
⌄
-4.8-5.1-4.9-3.9-5.1-5.6-6.2-7.1-8.6-8.6-7.6-7.2-7.7
Diluted NI Avail to Com Stockholders Ann.
-4.8-5.1-4.9-3.9-5.1-5.6-6.2-7.1-8.6-8.6-7.6-7.2-7.7
Basic EPS
-0.3-0.3-0.5-0.9-1.2-2.1-1.2-4.5-5.7-6-6.3-6.9-8.1
Diluted EPS After ExtraOrdinary
-0.3-0.3-0.5-0.9-1.2-2.1-1.2-3.8-5.7-6-6.3-6.9-8.1
Number Of Shares End
19.519.59.84.54.12.82.61.61.51.41.21.11
Net Income Continuing Discontinued Operations
-4.8-5.1-4.9-3.9-5.1-5.6-6.2-7.1-8.6-8.6-7.6-7.2-7.7
Normalized Income
-4.8-5.1-4.9-3.9-5.1-5.6-6.2-6-8.6-8.6-7.6-7.2-7.7
Interest Income
0.20.20.10.10.10.10.100.10.1---
Interest
-------------
Net Interest Income
0.20.20.10.10.10.10.100.10.1---
EBIT
-4.9-5.3-5-4-5.2-5.7-6.2-6-8.7-8.6-7.9-7.2-7.7
EBITDA
-4.5-4.8-4.5-3.4-4.4-5-5.5-5.4-8.1-8-7.3-6.5-7.1
Reconciled Cost Of Rev.
-------------
Reconciled Depr.
0.50.50.50.50.80.70.70.70.60.60.60.70.6
Profit From Continuing Operations
-4.8-5.1-4.9-3.9-5.1-5.6-6.2-7.1-8.6-8.6-7.6-7.2-7.7
Normalized EBITDA
-4.5-4.8-4.5-3.4-4.4-5-5.5-4.3-8.1-8-7.3-6.5-7.1
*All financials are in USD Million and price data in USD
Add metric to table
Search...

IN8bio Inc competitor comparison and performance snapshot within industry

IN8bio Inc annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEUTRAL

    Annual Revenue IN8bio Inc Annual Revenue is $0 Million which is growth of 0% YoY.

  • POSITIVE

    Annual Net Profit IN8bio Inc Annual Net Profit is $-19 Million which is growth of 36.1% YoY.

IN8bio Inc, Earnings Report - Annual Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsTTMDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18
⌄
-
-
 
Cost Of Rev. Ann.
-
-
 --------
Gross Profit Ann.
-
-
 --------
Operating Exp. Ann.
-11.3%
18.3%
19.219.929.630.328.514.78.65.12
Operating Profit Ann.
-
-
-19.2-19.9-29.6-30.3-28.5-14.7-8.6-5.1-2
⌄
-
-
0.50.40.2-----0
Other Exp. Ann.
-
-
 --1.10.3----0.1-0.1
PBT Ann.
-
-
-18.7-19.4-30.4-30-28.5-14.7-8.6-5.1-2.1
Tax Ann.
-
-
 --------
⌄
-
-
-18.7-19.4-30.4-30-28.5-14.7-8.6-5.1-2.5
Diluted NI Avail to Com Stockholders Ann.
-
-
-18.7-19.4-30.4-30-28.5-14.7-8.6-5.1-2.5
EPS Ann.
-
-
 -4.4-17.1-30-40.8-44.1-27.3-24.9-12.2
Diluted EPS Ann.
-
-
 -4.4-17.1-30-40.8-44.1-27.3-24.9-12.2
Number Of Shares End
130.5%
69.5%
 9.82.61.20.80.60.719.4-
Total Exp. Ann.
-11.3%
18.3%
 19.929.630.328.514.78.65.12
Net Income Continuing Discontinued Operations Ann.
-
-
-18.7-19.4-30.4-30-28.5-14.7-8.6-5.1-2.1
Normalized Income Ann.
-
-
-18.7-19.4-29.4-30-28.5-14.7-8.6-5.1-2.1
Interest Income Ann.
-
-
0.50.40.2------
Interest Ann.
-
-
 ------0
EBITDA Ann.
-
-
-17.2-17.4-26.9-27.8-27.4-13.9-8.5-5-2
Reconciled Cost Of Rev. Ann.
-
-
 --------
Reconciled Depr. Ann.
31.5%
90.4%
22.52.72.51.10.80.10.10.1
Profit From Continuing Operations Ann.
-
-
-18.7-19.4-30.4-30-28.5-14.7-8.6-5.1-2.1
Normalized EBITDA Ann.
-
-
-17.2-17.4-25.9-27.8-27.4-13.9-8.5-5-2
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Operating Exp. Ann.
1Y CHG
-32.8%
2Y CAGR
-19%
3Y CAGR
-11.3%
5Y CAGR
18.3%
7Y CAGR
38.9%
Operating Expenses Annual Cr is falling faster than historical averages.

IN8bio Inc balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • POSITIVE

    Total Shareholders Fund IN8bio Inc Dec-2025 Total Shareholders Fund is $28 Million which is growth of 90.3% YoY.

  • POSITIVE

    Total Assets IN8bio Inc Dec-2025 Total Assets is $32 Million which is growth of 54.1% YoY.

IN8bio Inc, Balance Sheet, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18
⌄
-0.7%
9.1%
32.320.933.73342.220.91.15.9
⌄
-23%
12.6%
4.76.58.810.342.61.51.3
⌄
6.7%
-
27.614.524.922.738.2-16.6-9.2-4.3
Total Capitalization Ann.
6.7%
8.6%
27.614.524.922.738.218.3-0.44.7
Tangible Assets Ann.
6.7%
8.6%
27.614.524.922.738.218.3-0.44.7
Working Capital Ann.
14.6%
9.6%
24.79.519.216.436.715.60.14.7
Invested Capital Ann.
6.7%
-
27.614.524.922.738.2-16.4-9.2-4.3
Tangible Book Value Ann.
6.7%
-
27.614.524.922.738.2-16.6-9.2-4.3
Borrowings Ann.
-22%
69.5%
2.854.95.92.40.2--
Net Debt Ann.
-
-
--------
Share Issued Ann.
130.5%
69.5%
9.82.41.40.80.60.70.70.7
Number Of Shares End
130.5%
69.5%
9.82.61.20.80.60.719.4-
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Total Assets Ann.
1Y CHG
54.5%
2Y CAGR
-2.1%
3Y CAGR
-0.7%
5Y CAGR
9.1%
7Y CAGR
27.5%
Total Assets Annual growth is higher than historical averages.
Total Current Liabilities Ann.
1Y CHG
3.2%
2Y CAGR
-23%
3Y CAGR
-18%
5Y CAGR
4.2%
7Y CAGR
34.6%
Total Current Liabilities Annual Cr growth is stable compared to historical averages.
Total ShareHolders Funds Ann.
1Y CHG
90.3%
2Y CAGR
5.3%
3Y CAGR
6.7%
Total ShareHolders Funds Annual growth is stable compared to historical averages.

IN8bio Inc ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEGATIVE

    Book Value Per Share IN8bio Inc Book Value Per Share is $2 which is growth of -41.3% YoY.

  • NEUTRAL

    ROE IN8bio Inc ROE is 0% which is growth of 0% YoY.

IN8bio Inc, Ratios, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18
RoA Ann. %
-
-
--111.38%-89.91%-75.79%-46.42%-77.65%-146.16%-42.56%
ROE Ann. %
-
-
--154.44%-125.90%-93.64%-135.65%---
ROIC %
-
-
--37.1-28.8-24.8-13.6---
OPM Ann. %
-
-
--------
Inventory Turnover Ratio Ann.
-
-
--------
Asset Turnover Ann. %
-
-
--------
Working Capital Turnover Ann.
-
-
Quick Ratio Ann.
-
-
-3.643.116.470.912
Current Ratio Ann.
-
-
-4.14.63.817.37.11.212.1
Interest Coverage Ratio Ann.
-
-
--------147.6
LT Debt To Equity Ann.
-
-
-0.20.10.20.1---
*All financials are in USD Million and price data in USD
Add metric to table
Search...

IN8bio Inc cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • POSITIVE

    Cash From Operating Activity IN8bio Inc Cash From Operating Activity is $-13 Million which is growth of 47.4% YoY.

  • POSITIVE

    Net Cash Flow IN8bio Inc Net Cash Flow is $16 Million which is growth of 256.9% YoY.

IN8bio Inc, Cash Flow, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18
⌄
-
-
-12.7-24.2-23.3-24.1-13.5-7.1-4.8-2.8
⌄
-
-
-0.2-0.6-3.7-0.30.4-0.8
⌄
47%
3.1%
28.614.22793324.50.18.5
Cash Plus Cash Eqv. End Of Year Ann.
13.8%
8.5%
27.111.121.318.437.3180.65
Net Increase In Cash Plus Cash Eqv.s Ann.
-
-1.8%
15.9-10.22.9-18.819.117.4-4.45
Cash Plus Cash Eqv. Begin Of Year Ann.
-32.6%
80.2%
11.421.518.437.318.10.650
Income Tax Paid Supplemental Data Ann.
-
-
--------
Interest Paid Supplemental Data Ann.
-
-
------0
Capex Ann.
-
-
--0.2-0.6-3.7-0.3--0.3-0.8
Issuance Of Capital Stock Ann.
41.8%
1.1%
27.19.924.69.536.325.77.2
Issuance Of Debt Ann.
-
-
----0.22.1
Repayment Of Debt Ann.
-
-
-0.7-0.8-0.8-0.6-0.7--0.8
Repurchase Of Capital Stock Ann.
-
-
--------
Free Cash Flow Ann.
-
-
-12.7-24.3-23.9-27.8-13.8-7.1-5.1-3.5
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Cash from Financing Act. Ann.
1Y CHG
101.4%
2Y CAGR
2.9%
3Y CAGR
47%
5Y CAGR
3.1%
7Y CAGR
18.9%
Cash from Financing Annual Activity growth is higher than historical averages.
×